PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.25%
Positive revenue growth while 3088.T is negative. John Neff might see a notable competitive edge here.
6.66%
Positive gross profit growth while 3088.T is negative. John Neff would see a clear operational edge over the competitor.
45.88%
Positive EBIT growth while 3088.T is negative. John Neff might see a substantial edge in operational management.
51.13%
Positive operating income growth while 3088.T is negative. John Neff might view this as a competitive edge in operations.
46.91%
Positive net income growth while 3088.T is negative. John Neff might see a big relative performance advantage.
46.89%
Positive EPS growth while 3088.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
46.89%
Positive diluted EPS growth while 3088.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3088.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
68.51%
10Y revenue/share CAGR above 1.5x 3088.T's 45.40%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
64.78%
5Y revenue/share CAGR above 1.5x 3088.T's 13.94%. David Dodd would look for consistent product or market expansions fueling outperformance.
35.69%
3Y revenue/share CAGR above 1.5x 3088.T's 5.89%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
100.00%
Positive long-term OCF/share growth while 3088.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
202.11%
Net income/share CAGR 1.25-1.5x 3088.T's 168.96%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
95.22%
5Y net income/share CAGR 1.25-1.5x 3088.T's 74.04%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
40.35%
3Y net income/share CAGR above 1.5x 3088.T's 7.32%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
201.46%
10Y equity/share CAGR above 1.5x 3088.T's 119.69%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
125.07%
5Y equity/share CAGR above 1.5x 3088.T's 47.08%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
58.34%
3Y equity/share CAGR above 1.5x 3088.T's 24.57%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.90%
Firm’s AR is declining while 3088.T shows 0.74%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.06%
Inventory is declining while 3088.T stands at 9.01%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.11%
Positive asset growth while 3088.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.35%
BV/share growth above 1.5x 3088.T's 1.92%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.77%
We’re deleveraging while 3088.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.60%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.